X. Sáez-Llorens Et Al. , "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial," JOURNAL OF INFECTIOUS DISEASES , vol.229, no.1, pp.95-107, 2024
Sáez-Llorens, X. Et Al. 2024. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial. JOURNAL OF INFECTIOUS DISEASES , vol.229, no.1 , 95-107.
Sáez-Llorens, X., Norero, X., Mussi-Pinhata, M. M., Luciani, K., de la Cueva, I. S., Díez-Domingo, J., ... Lopez-Medina, E.(2024). Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial. JOURNAL OF INFECTIOUS DISEASES , vol.229, no.1, 95-107.
Sáez-Llorens, Xavier Et Al. "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial," JOURNAL OF INFECTIOUS DISEASES , vol.229, no.1, 95-107, 2024
Sáez-Llorens, Xavier Et Al. "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial." JOURNAL OF INFECTIOUS DISEASES , vol.229, no.1, pp.95-107, 2024
Sáez-Llorens, X. Et Al. (2024) . "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial." JOURNAL OF INFECTIOUS DISEASES , vol.229, no.1, pp.95-107.
@article{article, author={Xavier Sáez-Llorens Et Al. }, title={Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial}, journal={JOURNAL OF INFECTIOUS DISEASES}, year=2024, pages={95-107} }